ACTRN 12623001338651 Brief Summary The purpose of this trial is to assess…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design…
Read more arrow_forwardNCT 05694936 Brief Summary The aim of this study is to determine…
Read more arrow_forwardNCT 06907641 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 04319783 Brief Summary Darolutamide is a drug that has a proven…
Read more arrow_forwardNCT 05911295 Brief Summary This study will enroll participants with urothelial cancer…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 03275103 Brief Summary This is a phase I, multicenter, open-label, dose-escalation…
Read more arrow_forwardNCT 02821013 Brief Summary The purpose of this study is to…
Read more arrow_forward